AAAAAA
Results:
1-19
|
Results: 19
Authors:
WOZNIAK AJ
CROWLEY JJ
BALCERZAK SP
WEISS GR
SPIRIDONIDIS CH
BAKER LH
ALBAIN KS
KELLY K
TAYLOR SA
GANDARA DR
LIVINGSTON RB
Citation: Aj. Wozniak et al., RANDOMIZED TRIAL COMPARING CISPLATIN WITH CISPLATIN PLUS VINORELBINE IN THE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 16(7), 1998, pp. 2459-2465
Authors:
SUGAWARA Y
FISHER SJ
ZASADNY KR
KISON PV
BAKER LH
WAHL RL
Citation: Y. Sugawara et al., PRECLINICAL AND CLINICAL-STUDIES OF BONE-MARROW UPTAKE OF FLUORINE-18-FLUORODEOXYGLUCOSE WITH OR WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR DURING CHEMOTHERAPY, Journal of clinical oncology, 16(1), 1998, pp. 173-180
Authors:
CARLSON MJ
BAKER LH
Citation: Mj. Carlson et Lh. Baker, DIFFICULT, DANGEROUS, AND DRUG SEEKING - THE 3D WAY TO BETTER PATIENT-CARE, American journal of public health, 88(8), 1998, pp. 1250-1252
Authors:
ANTMAN K
CROWLEY J
BALCERZAK SP
KEMPF RA
WEISS RB
CLAMON GH
BAKER LH
Citation: K. Antman et al., A SOUTHWEST-ONCOLOGY-GROUP AND CANCER AND LEUKEMIA GROUP-B PHASE-II STUDY OF DOXORUBICIN, DACARBAZINE, IFOSFAMIDE, AND MESNA IN ADULTS WITHADVANCED OSTEOSARCOMA, EWINGS-SARCOMA, AND RHABDOMYOSARCOMA, Cancer, 82(7), 1998, pp. 1288-1295
Authors:
TIERNEY JF
STEWART LA
PARMAR MKB
FLETCHER CDM
JONES G
MOSSERI V
PATEL M
DEELVIRA MCR
SOUHAMI RL
SYLVESTER R
TURSZ T
ALVEGARD TA
SIGURDSSON H
ANTMAN K
BACCHI M
BAKER LH
BENJAMIN RS
BRADY MF
BRAMWELL V
BUI BN
EDMONSON JH
LEYVRAZ S
OMURA GA
ROUESSE J
RYAN L
VANOOSTEROM AT
YANG JC
Citation: Jf. Tierney et al., ADJUVANT CHEMOTHERAPY FOR LOCALIZED RESECTABLE SOFT-TISSUE SARCOMA OFADULTS - METAANALYSIS OF INDIVIDUAL DATA, Lancet, 350(9092), 1997, pp. 1647-1654
Authors:
BIERMANN JS
BAKER LH
Citation: Js. Biermann et Lh. Baker, THE FUTURE OF SARCOMA TREATMENT, Seminars in oncology, 24(5), 1997, pp. 592-597
Authors:
SCHWARTZ SW
CHAMBLESS LE
BAKER LH
BRODERICK JP
HOWARD G
Citation: Sw. Schwartz et al., CONSISTENCY OF DOPPLER PARAMETERS IN PREDICTING ARTERIOGRAPHICALLY CONFIRMED CAROTID STENOSIS, Stroke, 28(2), 1997, pp. 343-347
Authors:
JOOS SK
HICKAM DH
GORDON GH
BAKER LH
Citation: Sk. Joos et al., EFFECTS OF A PHYSICIAN COMMUNICATION INTERVENTION ON PATIENT-CARE OUTCOMES, Journal of general internal medicine, 11(3), 1996, pp. 147-155
Authors:
BAKER LH
MOON P
MOURINO AP
Citation: Lh. Baker et al., RETENTION OF AESTHETIC VENEERS ON PRIMARY STAINLESS-STEEL CROWNS, Journal of dentistry for children, 63(3), 1996, pp. 185
Authors:
FOSTER BJ
WIEGAND RA
LORUSSO PM
BAKER LH
Citation: Bj. Foster et al., PHARMACOKINETICS OF 9-METHOXY-N, N-DIMETHYL-5-NITROPYRAZOLO [3,4,5-KL]ACRIDINE-2(6H)-PROPANAMINE (PZA, PD-115934, NSC-366140) IN MICE - GUIDELINES FOR EARLY CLINICAL-TRIALS, Clinical cancer research, 1(8), 1995, pp. 831-837
Authors:
ZALUPSKI MM
BAKER LH
Citation: Mm. Zalupski et Lh. Baker, SYSTEMIC ADJUVANT CHEMOTHERAPY FOR SOFT-TISSUE SARCOMAS, Hematology/oncology clinics of North America, 9(4), 1995, pp. 787-800
Authors:
DJURIC Z
CORBETT TH
VALERIOTE FA
HEILBRUN LK
BAKER LH
Citation: Z. Djuric et al., DETOXIFICATION ABILITY AND TOXICITY OF QUINONES IN MOUSE AND HUMAN TUMOR-CELL LINES USED FOR ANTICANCER DRUG SCREENING, Cancer chemotherapy and pharmacology, 36(1), 1995, pp. 20-26
Authors:
FOSTER BJ
LORUSSO PM
POPLIN E
ZALUPSKI M
VALDIVIESO M
WOZNIAK A
FLAHERTY L
KASUNIC DA
EARHART RH
BAKER LH
Citation: Bj. Foster et al., PHASE-I TRIAL OF ADOZELESIN USING THE TREATMENT SCHEDULE OF DAILY X 5EVERY 3 WEEKS, Investigational new drugs, 13(4), 1995, pp. 321-326
Authors:
BAKER LH
LIEBERMAN D
OEHLKE M
Citation: Lh. Baker et al., PSYCHOLOGICAL DISTRESS IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE, The American journal of gastroenterology, 90(10), 1995, pp. 1797-1803
Authors:
MOMIN FA
ZALUPSKI M
HEILBRUN LK
FLAHERTY L
FYFE G
BAKER LH
REDMAN BG
Citation: Fa. Momin et al., PHASE-II TRIAL OF RECOMBINANT HUMAN MACROPHAGE-COLONY-STIMULATING FACTOR IN METASTATIC SOFT-TISSUE SARCOMA, Journal of immunotherapy with emphasis on tumor immunology, 16(3), 1994, pp. 224-228
Authors:
BLAIR SC
ZALUPSKI MM
BAKER LH
Citation: Sc. Blair et al., IFOSFAMIDE AND ETOPOSIDE IN THE TREATMENT OF ADVANCED SOFT-TISSUE SARCOMAS, American journal of clinical oncology, 17(6), 1994, pp. 480-484
Authors:
CORDON GH
BAKER LH
BOVERMAN J
Citation: Gh. Cordon et al., SUCCESSFUL MEDICAL AND PSYCHOLOGICAL MANAGEMENT OF RECURRING CHEST PAIN AND FREQUENT HOSPITAL ADMISSIONS IN A PATIENT WITH CORONARY-ARTERY DISEASE, Western journal of medicine, 160(4), 1994, pp. 371-375
Authors:
ANTMAN K
CROWLEY J
BALCERZAK SP
RIVKIN SE
WEISS GR
ELIAS A
NATALE RB
COOPER RM
BARLOGIE B
TRUMP DL
DOROSHOW JH
AISNER J
PUGH RP
WEISS RB
COOPER BA
CLAMOND GH
BAKER LH
Citation: K. Antman et al., AN INTERGROUP PHASE-III RANDOMIZED STUDY OF DOXORUBICIN AND DACARBAZINE WITH OR WITHOUT IFOSFAMIDE AND MESNA IN ADVANCED SOFT-TISSUE AND BONE SARCOMAS, Journal of clinical oncology, 11(7), 1993, pp. 1276-1285
Authors:
ZALUPSKI MM
RYAN JR
ENSLEY JF
MACIOROWSKI Z
PIETRASZKIEWICZ H
HUSSEIN ME
KUKURUGA M
SUNDARESON AS
BAKER LH
Citation: Mm. Zalupski et al., DEVELOPMENT AND OPTIMIZATION OF TISSUE PREPARATIVE METHODOLOGY FOR DNA CONTENT-ANALYSIS OF SOFT-TISSUE NEOPLASMS, Cytometry, 14(8), 1993, pp. 922-930
Risultati:
1-19
|